Immediate Impact
2 by Nobel laureates 15 from Science/Nature 56 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Natural killer cell therapies
2024 StandoutNature
Works of Gregory M. Coté being referenced
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule
2020
Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Gregory M. Coté | 1330 | 1232 | 1228 | 148 | 3.3k | |
| Stefania Benini | 1625 | 860 | 1377 | 89 | 3.1k | |
| Elizabeth R. Lawlor | 1594 | 1080 | 1887 | 89 | 3.7k | |
| Christina L. Roland | 1386 | 1666 | 931 | 125 | 3.5k | |
| Li‐Xuan Qin | 2255 | 1820 | 850 | 109 | 3.6k | |
| Keila E. Torres | 1633 | 1307 | 958 | 94 | 3.2k | |
| Justin Cates | 1431 | 1102 | 1073 | 152 | 3.7k | |
| Elizabeth G. Demicco | 1748 | 1283 | 970 | 102 | 4.0k | |
| Andrew Horvai | 1061 | 804 | 768 | 113 | 3.0k | |
| Maud Toulmonde | 1281 | 1220 | 674 | 113 | 2.4k | |
| Neeta Somaiah | 1668 | 1387 | 764 | 164 | 2.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...